PRAM9
DPI-201
Phase 2 small_molecule completed
Quick answer
PRAM9 for Diabetes Mellitus, Type 1 is a Phase 2 program (small_molecule) at Xeris Biopharma Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xeris Biopharma Holdings
- Indication
- Diabetes Mellitus, Type 1
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed